| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
135,941,169.41 | 114,061,538.47 | 64,851,303.83 | 56,227,378.92 | 60,181,806.97 |
| Cost of Revenue
|
-75,532,211.52 | -63,384,963.03 | -43,521,158.23 | -40,735,416.37 | -36,362,213 |
|
Gross Profit
|
60,408,957.89 | 50,676,575.44 | 21,330,145.60 | 15,491,962.55 | 23,819,593.97 |
| Selling, General and Administrative Expenses
|
-8,788,421 | -9,051,438 | -8,153,271 | -7,142,882 | -7,605,918 |
|
Research and Development Expenses
|
-6,960,261 | -6,714,561 | -7,886,804 | -6,544,418 | -6,884,276 |
| Depreciation, Amortization and Depletion
|
-593,557 | -606,542 | -634,434 | -508,666 | -456,033 |
|
Operating Income/Expenses
|
-16,342,239 | -16,372,541 | -16,674,509 | -14,195,966 | -14,946,227 |
|
Total Operating Profit/Loss
|
44,066,718.89 | 34,304,034.44 | 4,655,636.60 | 1,295,996.55 | 8,873,366.97 |
| Total Net Finance Income/Expense
|
692,755.34 | 615,343.61 | 319,183 | 1,180,939.84 | -415,372.71 |
| Net Investment Income
|
-300,186 | -300,186 | 1,548,925 | -398,027 | -2,390,541 |
| Irregular Income/Expenses
|
-34,674 | -34,674 | -22,345 | 1,487,765 | -655,564 |
|
Other Income/Expense, Non-Operating
|
2,489,371.32 | 182,849 | -237,425 | 1,165,383 | 557,068 |
|
Non-Operating Income/Expenses, Total
|
2,847,266.66 | 463,332.61 | 1,608,338 | 3,436,060.84 | -2,904,409.71 |
|
Pretax Income
|
46,913,985.01 | 34,767,366.55 | 6,263,974.72 | 4,732,057.18 | 5,968,957.59 |
|
Provision for Income Tax
|
5,521,619.84 | 5,521,619.84 | 67,302.28 | -1,154,073.54 | 2,292,811.23 |
|
Net Income from Continuing Operations
|
46,533,236.69 | 40,288,986.39 | 6,331,277 | 3,577,983.63 | 8,261,768.82 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
46,533,236.69 | 40,288,986.39 | 6,331,277 | 3,577,983.63 | 8,261,768.82 |
|
Net Income after Non-Controlling/Minority Interests
|
46,533,236.69 | 40,288,986.39 | 6,331,277 | 3,577,983.63 | 8,261,768.82 |
| Basic EPS
|
775.00 | 671.00 | 106.00 | 60.00 | 138.00 |
| Diluted EPS
|
775.00 | 671.00 | 106.00 | 60.00 | 138.00 |
|
Basic Weighted Average Shares Outstanding
|
60,004.01 | 60,004.01 | 60,004.01 | 60,004.01 | 59,946 |
|
Diluted Weighted Average Shares Outstanding
|
60,004.01 | 60,004.01 | 60,004.01 | 60,004.01 | 59,946 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
46,913,985.01 | 34,142,033.55 | 6,111,114.72 | 5,325,143.18 | 6,384,330.59 |
|
EBITDA
|
49,928,296.01 | 37,176,951.55 | 9,174,016.72 | 8,166,551.18 | 8,569,591.59 |
|
Normalized EBITDA
|
50,529,385.01 | 40,107,334.55 | 9,522,552.72 | 8,107,211.18 | 16,632,594.59 |
|
Normalized Income
|
46,990,064.33 | 42,516,077.47 | 6,596,164.36 | 3,533,115.71 | 14,107,446 |
|
Total Unusual Items
|
601,089 | 2,930,383 | 348,536 | -59,340 | 8,063,003 |
|
Total Unusual Items Excluding Goodwill
|
601,089 | 2,930,383 | 348,536 | -59,340 | 8,063,003 |
|
Tax Effect of Unusual Items
|
144,261.36 | 703,291.92 | 83,648.64 | -14,472.08 | 2,217,325.83 |
12/31/2022 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade